Live Breaking News & Updates on Inform Diagnostics

Stay updated with breaking news from Inform diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript February 28, 2024 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […] ....

United States , Paul Kim , Chief Financial , Inform Diagnostics , Most Beautiful Castles , With Worst Vision ,

Fulgent Moves Beyond Covid - Los Angeles Business Journal

For El Monte-based clinical diagnostic testing company Fulgent Genetics Inc., the Covid testing surge that catapulted the company from $32 million in annual revenue to the doorstep of $1 billion in just two years has now all but ended. ....

United States , Sankt Peterburg , New York , Andrew Cooper , El Monte , Brandon Perthuis , Ming Hsieh , Raymond James , Fulgent Genetics Inc , Diagnostics Inc , For El Monte Based , Los Angeles County , New York City , Business Journal , Texas Based Inform Diagnostics , Avista Capital Partners , Inform Diagnostics , Fulgent Genetics , Fulgent Pharma , Fulgent Genetic , Florida Based Raymond James ,

What To Expect From Fulgent Genetics In 2023 (NASDAQ:FLGT)

The company is continuing its Phase 1 clinical trial evaluating the efficacy of FID-007 in treating various types of cancer. See why FLGT stock is a Hold. ....

United States , Ming Hsieh , Bioreference Health , Fulgent Genetic , Wall Street , Fulgent Genetics , Quest Diagnostics , Reference Health , Inform Diagnostics , Investor Presentation , Fulgent Pharma ,